Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform

Fig. 7

Thyroxine (T4) release by on-chip thyroid tissue. Concentration of T4 in effluent samples collected throughout the culture of both malignant (n = 7) and benign (n = 7) thyroid tissue explants on the PCTS device. Overall T4 release by benign thyroid tissue was significantly higher than that of malignant thyroid tissue (p = 0.03; 2-way ANOVA). Results normalised mg− 1 tissue

Back to article page